Table VII.
Association between the expression of miR-215 and clinicopathological parameters of gastric cancer.
| Variable | Cases, n (%) | Expression of miR-215, median ± range | P-value |
|---|---|---|---|
| Gender | 0.134 | ||
| Male | 32 (57) | 4.750±0.840 | |
| Female | 24 (43) | 3.437±0.441 | |
| Age, years | 0.285 | ||
| ≤50 | 18 (32) | 3.479±0.553 | |
| >50 | 38 (68) | 4.366±0.596 | |
| Tumor size, cm | 0.171 | ||
| ≤5 | 31 (55) | 4.448±0.561 | |
| >5 | 25 (45) | 3.355±0.571 | |
| Degree of differentiation | 0. 039* | ||
| Well and moderately | 17 (30) | 5.408±0.704 | |
| Poorly | 39 (70) | 3.056±0.500 | |
| TNM stage | 0.047* | ||
| I/II | 27 (48) | 4.985±0.674 | |
| III/IV | 29 (52) | 3.042±0.484 | |
| Lymph-node status | 0.001* | ||
| No metastasis | 6 (11) | 7.583±0.386 | |
| Metastasis | 50 (89) | 3.413±0.383 |
miR, microRNA; TNM, tumor node metastasis.